An analysis highlights the superiority of triptans such as eletriptan and rizatriptan over newer migraine drugs and common painkillers. Advocating for their increased use globally could standardize effective migraine care, say researchers. Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published [...]from SciTechDaily https://ift.tt/16vY4Fl
